• Facing
    Metastatic Cancer
    • Is Metastatic Cancer Curable?
    • Access to the Right Treatment
    • Registering with Cancer Commons
    • Enroll in XCELSIOR
    • Can a Virtual Tumor Board Help?
    • Get Help With Your Treatment Plan
  • New Cancer Research
    & Perspectives
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • Our Story
    • It Started in 1998…
    • We’re Here to Help
    • Why We Go to Work Each Day
    • Our Services
    • Meet the Team
    • Why we built a “Commons”
    • Our Partners
    • Keeping Our Services Free
    • Talk to Us
  • Support Our
    Free Services
    • Donate Now
    • Many Ways to Give
    • Funding Initiatives
    • What Your Support Makes Possible
  • Facing
    Metastatic Cancer
    • Is Metastatic Cancer Curable?
    • Access to the Right Treatment
    • Registering with Cancer Commons
    • Enroll in XCELSIOR
    • Can a Virtual Tumor Board Help?
    • Get Help With Your Treatment Plan
  • New Cancer Research
    & Perspectives
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • Our Story
    • It Started in 1998…
    • We’re Here to Help
    • Why We Go to Work Each Day
    • Our Services
    • Meet the Team
    • Why we built a “Commons”
    • Our Partners
    • Keeping Our Services Free
    • Talk to Us
  • Support Our
    Free Services
    • Donate Now
    • Many Ways to Give
    • Funding Initiatives
    • What Your Support Makes Possible
  • Donate
 

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

November 24, 2020
Focus: Liver Cancer
Topics: Clinical Trial Results

This academic research paper from The New England Journal of Medicine reports results from a clinical trial in which a treatment that combines the drugs atezolizumab and bevacizumab improved both progression-free and overall survival for people with unresectable primary liver cancer.

.

Tags: atezolizumab, Bevacizumab, unresectable liver cancer

Cancer Commons is a nonprofit that provides hope to advanced cancer patients by helping them identify and access their best possible treatment. We offer a highly customized experience, connecting patients with our collaborative network of nurse navigators, PhD scientists, and national experts. We learn from every patient we serve, so we can help many more.

Get free advice on cancer treatment options

Patient Services

  • Get Access to the Right Treatment
  • Request an Options Report
  • Frequently Asked Questions (FAQ)

Perspectives

  • Latest Research & Perspectives
  • Treatment Options
  • Navigating Treatment
  • Living with Cancer
  • Patient Stories
  • Curious Dr. George
  • The Big Picture
  • COVID-19 and Cancer
  • Peer-Reviewed Publications

Organization

  • Our Story
  • The Team
  • Board of Directors
  • Advisory Board
  • The Commons
  • Partners
  • Expert Physician Advisors
  • Open Positions

Corporate & Regulatory

  • News and Events
  • Funding Initiatives
  • Contact Us
  • Cancer Commons International
  • Audited Financials

Support & Giving

  • Donate
  • Other Ways to Give
  • Funding Initiatives
  • What Your Support Makes Possible


Donate

Cancer Commons
650 Castro Street, Suite 120-522
Mountain View, CA 94041, USA
650-289-4044

Patients Hotline

877-971-1200

If you have advanced or metastatic cancer, and you are a U.S. resident, our experts are here to help you identify the best-possible treatment options—all at no cost to you. Our one-on-one support is driven by the latest, evidence-based scientific discoveries.

To get started, simply fill out this form. You will then receive an email with a link to submit additional information.

The sooner we receive all of your information, the sooner we can help.

  • Privacy Policy

© 2021 Cancer Commons.